Holdings

Saturn V Capital Management LP

As of Sep 30, 2026, Saturn V Capital Management LP reported 21 positions worth US$596M. Largest: Amylyx Pharmaceuticals, Inc., Abivax SA and Immix Biopharma, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Amylyx Pharmaceuticals, Inc.4.47MUS$130M−153KSep 30, 2026
Abivax SA529KUS$52.4M+10,448Sep 30, 2026
Immix Biopharma, Inc.4.66MUS$48.5M+2,686Sep 30, 2026
Vaxcyte, Inc.772KUS$43.9M−80,656Sep 30, 2026
Celcuity Inc.514KUS$40.9M+144KSep 30, 2026
Disc Medicine, Inc.613KUS$40.1M+87,931Sep 30, 2026
Candel Therapeutics, Inc.3.48MUS$36.3M+173KSep 30, 2026
Monopar Therapeutics Inc.312KUS$24.9M+374Sep 30, 2026
Vir Biotechnology, Inc.2.04MUS$22.8M+1.27MSep 30, 2026
Trevi Therapeutics, Inc.1.57MUS$22.5M+522KSep 30, 2026